Tapping the Potential of Probiotics: An Insight on Probiotic Delivery Systems, Their Quantification, and Assessment
| dc.contributor.author | Minkal Tuteja | |
| dc.contributor.author | Anupama Choudhary | |
| dc.contributor.author | Prince Rohilla | |
| dc.contributor.author | Gaurav Rohilla | |
| dc.date.accessioned | 2025-12-19T09:03:21Z | |
| dc.date.available | 2025-12-19T09:03:21Z | |
| dc.date.issued | 2023-11-10 | |
| dc.description.abstract | Background: Dysbiosis of the microbiota and gastrointestinal dysfunction are common characteristics of gastrointestinal diseases. Probiotics can alter the gut microbiota and serve as biological agents for treating digestive disorders. Although probiotics show promise in treating gastrointestinal disorders, several obstacles could hinder their effectiveness. These include concerns about safety, stress resistance, quantifying post-colonization, and evaluation methods. Purpose: The aim of this review is to introduce the probiotic delivery methods and their mechanisms of action. It also described the functions of bacteriocins in providing probiotic strains with an advantage over competing treatments and the challenges associated with widespread deployment. It also evaluates current fluorescence-induced methods and numerous laboratory experiments involving living organisms’ models for quantifying probiotics in complex microbiomes and assessing probiotic delivery systems. Method: The approach includes a systematic analysis of recent developments in encapsulation technologies, delivery mechanisms, and innovative strategies for enhancing probiotic stability and functionality. Result: The review found that encapsulation technologies have significantly evolved, with microencapsulation and nanoparticle systems being the most effective in ensuring the survival of probiotics through the gastrointestinal tract. Conclusion: Probiotics could be used in gastrointestinal illnesses more effectively as therapeutic agents. This review has shown that effective delivery systems are critical to ensuring the viability and functionality of probiotics throughout their journey from production to gastrointestinal colonization. In conclusion, while substantial strides have been made in probiotic delivery, quantification, and assessment, continued interdisciplinary research and collaboration are essential to fully harness the benefits of probiotics in healthcare. | |
| dc.identifier.issn | 2321-2217 | |
| dc.identifier.issn | 2321-2225 | |
| dc.identifier.other | https://doi.org/10.15415/jptrm.2023.112007 | |
| dc.identifier.uri | https://demodspace.chitkara.edu.in/handle/123456789/289 | |
| dc.language.iso | en | |
| dc.publisher | Chitkara University Publications | |
| dc.subject | Probiotics | |
| dc.subject | Quantification | |
| dc.subject | Gastrointestinal tract | |
| dc.subject | Delivery system | |
| dc.title | Tapping the Potential of Probiotics: An Insight on Probiotic Delivery Systems, Their Quantification, and Assessment | |
| dc.type | Article |